| Emcure Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544210 |
NSE Symbol : EMCURE |
P/E(TTM) : 44.37 |
|
ISIN Demat : INE168P01015 |
Div & Yield% : 0.19 |
EPS(TTM) : 43.64 |
|
Book Value(₹) : 195.63 |
Market Cap(₹Cr) : 36,723.97 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,450.93 | 1,467.70 | 1,418.31 | 1,260.60 | 1,096.57 | 1,278.19 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,450.93 | 1,467.70 | 1,418.31 | 1,260.60 | 1,096.57 | 1,278.19 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 25.03 | 34.52 | 138.30 | 22.75 | 21.52 | 22.40 |
| Total Income | 1,475.96 | 1,502.22 | 1,556.61 | 1,283.36 | 1,118.10 | 1,300.58 |
| Total Expenditure | 1,111.35 | 1,096.05 | 1,146.95 | 1,036.01 | 872.07 | 1,033.55 |
| PBIDT | 364.62 | 406.17 | 409.65 | 247.34 | 246.02 | 267.03 |
| Interest | 32.78 | 36.87 | 33.15 | 27.71 | 20.54 | 24.07 |
| PBDT | 331.84 | 369.31 | 376.50 | 219.63 | 225.49 | 242.96 |
| Depreciation | 63.17 | 63.04 | 62.14 | 61.74 | 59.82 | 56.91 |
| Tax | 70.35 | 78.86 | 64.89 | 45.98 | 44.00 | 63.59 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.78 | -6.29 | -9.38 | -5.71 | -1.12 | -17.10 |
| Reported Profit After Tax | 200.11 | 233.70 | 258.85 | 117.62 | 122.79 | 139.56 |
| Extra-ordinary Items | 0.00 | 5.63 | -23.13 | 0.00 | -2.57 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 200.11 | 228.07 | 281.98 | 117.62 | 125.36 | 139.56 |
| EPS (Unit Curr.) | 10.55 | 12.33 | 13.65 | 6.21 | 6.48 | 7.37 |
| EPS (Adj) (Unit Curr.) | 10.55 | 12.33 | 13.65 | 6.21 | 6.48 | 7.37 |
| Calculated EPS (Unit Curr.) | 10.55 | 12.33 | 13.65 | 6.20 | 6.48 | 7.37 |
| Calculated EPS (Adj) (Unit Curr.) | 10.55 | 12.33 | 13.65 | 6.20 | 6.48 | 7.37 |
| Calculated EPS (Ann.) (Unit Curr.) | 42.20 | 49.31 | 54.62 | 24.82 | 25.92 | 29.46 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 42.20 | 49.31 | 54.62 | 24.82 | 25.92 | 29.46 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 189.68 | 189.59 | 189.57 | 189.57 | 189.51 | 189.48 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 25.13 | 27.67 | 28.88 | 19.62 | 22.44 | 20.89 |
| PBDTM(%) | 22.87 | 25.16 | 26.55 | 17.42 | 20.56 | 19.01 |
| PATM(%) | 13.79 | 15.92 | 18.25 | 9.33 | 11.20 | 10.92 |
